Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10065


Purpose:

The purpose of this study is to help us better understand the cellular changes that may lead to the development of lung cancer. We want to compare people with a second primary lung cancer with those who have only a first primary lung cancer. We hope to use the information obtained in this study as the basis for future studies and will not regard the results from this study as final. We will analyze your blood cells and DNA to measure the changes in several genes that we believe may be involved in lung cancer. We also want to evaluate the capacity for your DNA to repair itself.


Criteria:

Inclusion Criteria: - Cases will be eligible for inclusion if: - They have been diagnosed with a second primary lung cancer, and - They speak English or a language for which we have a translated consent form, and - They understand and agree to sign informed consent, and - They agree to give us a blood sample, and - They agree to give us a tissue sample when part of normal clinical procedures, and - They agree to complete the study questionnaires, and - They agree to have their pathology information reviewed. This could include biopsy specimens. Controls will be eligible for inclusion if - They have been diagnosed with a first primary lung cancer, and - They speak English or a language for which we have a translated consent form, and - They understand and agree to sign informed consent, and - They agree to give us a blood sample, and - They agree to give us a tissue sample when part of normal clinical procedures, and - They agree to complete the study questionnaires, - They agree to have their pathology information reviewed. This will could include biopsy specimens. Exclusion Criteria: - Subjects who do not meet the inclusion criteria as either cases or controls will not be eligible for this study. - Control subjects who have a history of another cancer, other than nonmelanoma skin cancer or a first primary lung cancer, will not be eligible for this study. - Control subjects who otherwise meet the eligibility requirements above but who have had chemotherapy and/or are currently being treated with chemotherapy will be excluded from the functional assay, but not from the genotyping.


NCT ID:

NCT00611598


Primary Contact:

Principal Investigator
Irene Orlow, PhD
Memorial Sloan Kettering Cancer Center


Backup Contact:

N/A


Location Contact:

New York, New York 10065
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 19, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.